ticlopidine has been researched along with Bright Disease in 9 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 [(WxB)F1] male mice with myocardial infarction (MI) and systemic lupus erythematosus (SLE)." | 7.69 | Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus. ( Fujiwara, H; Nakamura, Y; Shibata, Y; Suzuka, H; Tanaka, M; Yoshifusa, H, 1995) |
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis." | 6.15 | Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986) |
| " The present study analyzes the effect of the platelet inhibitor clopidogrel on the early injury and subsequent repair phase of experimental anti-thy1 glomerulonephritis." | 3.72 | Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis. ( Daig, U; Eisenberg, R; Gaedeke, J; Krämer, S; Liefeldt, L; Neumayer, HH; Peters, H; Westenfeld, R, 2004) |
| "We examined the antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 [(WxB)F1] male mice with myocardial infarction (MI) and systemic lupus erythematosus (SLE)." | 3.69 | Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus. ( Fujiwara, H; Nakamura, Y; Shibata, Y; Suzuka, H; Tanaka, M; Yoshifusa, H, 1995) |
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peters, H | 1 |
| Eisenberg, R | 1 |
| Daig, U | 1 |
| Liefeldt, L | 1 |
| Westenfeld, R | 1 |
| Gaedeke, J | 1 |
| Krämer, S | 1 |
| Neumayer, HH | 1 |
| Ohtake, T | 1 |
| Kobayashi, S | 1 |
| Okamoto, K | 1 |
| Oka, M | 1 |
| Maesato, K | 1 |
| Yasu, T | 1 |
| Moriya, H | 1 |
| Ogawa, S | 1 |
| Naruse, T | 1 |
| Suzuka, H | 1 |
| Fujiwara, H | 1 |
| Tanaka, M | 1 |
| Yoshifusa, H | 1 |
| Nakamura, Y | 1 |
| Shibata, Y | 1 |
| Splendiani, G | 1 |
| Costanzi, S | 1 |
| Sturniolo, A | 1 |
| Passalacqua, S | 1 |
| Fulignati, P | 1 |
| Piccinni, G | 1 |
| Federico, F | 1 |
| Chiarelli, C | 1 |
| Izumino, K | 1 |
| Iida, H | 1 |
| Asaka, M | 1 |
| Mizumura, Y | 1 |
| Sasayama, S | 1 |
| Harker, LA | 2 |
| Grekas, D | 1 |
| Alivanis, P | 1 |
| Kalekou, H | 1 |
| Syrganis, C | 1 |
| Tourkantonis, A | 1 |
2 reviews available for ticlopidine and Bright Disease
| Article | Year |
|---|---|
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
3 trials available for ticlopidine and Bright Disease
| Article | Year |
|---|---|
Treatment of idiopathic glomerulonephritis in the elderly. Personal data.
Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Glomerulonephritis; Glomerulonephri | 1993 |
Are antiplatelet agents of value in the treatment of chronic glomerular disease?
Topics: Adult; Clinical Trials as Topic; Female; Follow-Up Studies; Glomerulonephritis; Humans; Male; Middle | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
5 other studies available for ticlopidine and Bright Disease
| Article | Year |
|---|---|
Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
Topics: Animals; Blood Platelets; Clopidogrel; Glomerulonephritis; Male; Nitric Oxide Synthase; Nitric Oxide | 2004 |
Ticlopidine-induced lupus with renal involvement.
Topics: Aged; Fibrinolytic Agents; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Lupus Erythematosus, | 2006 |
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Imm | 1982 |
Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus.
Topics: Analysis of Variance; Animals; Antigen-Antibody Complex; Blood Urea Nitrogen; Coronary Disease; Coro | 1995 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
Topics: Animals; Antibodies; Antigen-Antibody Complex; Cattle; Creatinine; Dipyridamole; Fluorescent Antibod | 1986 |